Metformin and mTOR Inhibitors: Allies against Ovarian and Breast Cancers

Isabella Dos Santos Guimarães¹, Nayara Gusmão Tessarollo¹, Diandra Zipinotti Dos Santos², Marcele Lorentz Mattos De Souza², Taciane Barbosa Henriques¹, Ian Victor Silva^1,3 and Leticia Batista Azevedo Rangel^1,4*

¹Biotechnology Program/RENORBIO, Health Sciences Center, Federal University of Espirito Santo, Vitoria, ES, Brazil

²Pharmacology and Biochemistry Program, Health Sciences Center, Federal University of Espirito Santo, Vitoria, ES, Brazil

³Department of Morphology, Health Sciences Center, Federal University of Espirito Santo, Vitoria, ES, Brazil

⁴Department of Pharmaceutical Sciences, Health Sciences Center, Federal University of Espirito Santo, Vitoria, ES, Brazil